Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis

Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis

(2016) Wan-Ju Lee et al.   PHARMACOTHERAPY

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

(2015) Jens Klotsche et al.   ANNALS OF THE RHEUMATIC DISEASES

Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study

(2015) Rebecca Davies et al.   Arthritis & Rheumatology

Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register

(2014) Marieke H Otten et al.   ANNALS OF THE RHEUMATIC DISEASES

Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors

(2014) M. L. Mannion et al.   JOURNAL OF RHEUMATOLOGY

Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries

(2014) Joost Swart et al.   Pediatric Rheumatology

Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting

(2014) Maarit Tarkiainen et al.   RHEUMATOLOGY

Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009

(2013) L. R. Harrold et al.   JOURNAL OF RHEUMATOLOGY

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

(2012) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study

(2012) William A Blumentals et al.   BMC MUSCULOSKELETAL DISORDERS

Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples

(2011) Jeremy A. Rassen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis

(2011) Michael A. Lane et al.   MEDICINE

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

(2010) D. Salmon-Ceron et al.   ANNALS OF THE RHEUMATIC DISEASES

Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments

(2010) László Maródi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Observational Studies of Infections in Rheumatoid Arthritis: A Metaanalysis of Tumor Necrosis Factor Antagonists

(2010) S. BERNATSKY et al.   JOURNAL OF RHEUMATOLOGY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Utilization Trends of Tumor Necrosis Factor Inhibitors Among Patients with Rheumatoid Arthritis in a United States Observational Cohort Study

(2009) S. J. LEE et al.   JOURNAL OF RHEUMATOLOGY

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

(2008) Alberto Alonso-Ruiz et al.   BMC MUSCULOSKELETAL DISORDERS

Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients

(2008) Nivedita M. Patkar et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE